Marked as
Last updated - January 28, 2026
User Score
Trust Score
Brand Score
Cencora disclosed a cyber incident exposing patient information, affecting at least 27 pharmaceutical and biotech clients. The breach involved personally identifiable information and protected health information, with ongoing reviews to determine the full scope.
Senior Director
High Risk
Based on the available data, we advise consumers to avoid this Company altogether.
This advisory is based on an aggregate risk score derived from OSINT, Adverse Media, Reviews, and Risk Factors identified in our research.
You are likely to be at great risk by engaging in any sort of consumer-related activity with this entity.
Medium Risk
Based on the available data, we advise employees to be mindful when considering or continuing work with this Company.
This advisory stems from a medium-risk score compiled from OSINT, Adverse Media, Reviews, and Risk Factors uncovered in our analysis.
Employment with this entity may involve moderate risks.
Based on the available data, we urge investors and bankers to avoid financial involvement with this Company.
This advisory is informed by an aggregate risk score based on OSINT, Adverse Media, Reviews, and Risk Factors identified through our investigation.
Engaging in investment or lending activities with this entity poses a substantial risk to your financial interests.
Safe to Onboard
Enhanced Due Diligence required
Do Not Onboard
Monitor adverse media every 6 months
File SAR (Suspicious Activity Report) is warranted
Escalation to compliance committee
None
Former Name
CEO
CFO
Established
Jurisdiction
Headquarters
Location
Industry
Revenue
Employees
Major Shareholder
Key Partnership
Market Capitalization
U.S. Healthcare Solutions Revenue
Acquisition
Funding
Ongoing Lawsuit
Healthcare Solutions Revenue
Cyber Incident
Data Breach Settlement
Opioid Directors Settlement
Cencora has faced scrutiny for its role in the opioid crisis, with allegations of inadequate monitoring and distribution of controlled substances.
In 2022, Cencora, formerly AmerisourceBergen, settled for $6.1 billion as part of a nationwide opioid lawsuit, accused of failing to report suspicious orders of prescription painkillers.
Some employee reviews on platforms like Glassdoor report dissatisfaction with management, workload, and lack of career advancement opportunities at Cencora.
Cencora was fined $260 million by the DEA in 2018 for failing to flag suspicious opioid orders, as reported by various media outlets.
There have been no widely reported allegations of anti-competitive behavior directly tied to Cencora in major media sources.
Regulatory and Compliance Screening
Litigation and Legal Proceedings
Reputational and Adverse Media Risks
Geographic and Jurisdictional Risk
What you see here scratches the surface
We offer reward for actionable intel
Cencora suffered a February 2024 breach exposing patient names, DOB, addresses, health diagnoses and prescription data.
First Detected
Sentiment Analysis
Reach
POV
Risk Factor
Type
Traffic Source
SERP
Share of Voice
Primary Keyword
Cencora directors settled for $111M after accusations of ignoring opioid oversupply risks and failing to enforce controls.
Cencora settled a $40M class action after a 2024 cyberattack exposed 1.43M patients’ personal and health data.
Other Red-Flags and Adverse News
Based on user engagement on this review profile, ProConsumer will decide to publish its Risk Audit report for public if a threshold engagement, traffic and user input is achieved.
Known Assets: [Real estate, investments, companies]
Suspicious Transactions
Liabilities: [Bankruptcies, defaults, debts]
Wealth Sources: [Legitimate / Unclear / High-risk]
Bank Relationships
Ultimate Beneficial Owner(s) (UBOs)
Shareholding structure
Associated entities & subsidiaries
Offshore / shell company links
Trusts / Nominee arrangements
Business Model Assessment
All comments are user-generated content and may not be verified. They represent the personal opinions of the public and should not be relied upon. These comments do not influence or determine our overall rating.
1.7
2.3
3
Highly experienced
Well-recognized name
Faced allegations of scamming others
Allegedly sold fake silver
Sued multiple times
Unregulated industry
Alarming number of complaints online
Δ
I experienced frequent breakdowns in communication between management and staff. Important updates often came late or without enough clarity. This caused confusion and rework. Over time, it made collaboration harder than it should have been.
2/5
3/5
I often felt leadership was reactive instead of proactive. Decisions were usually made too late to be effective.
It’s crazy that his felony property damage charge was dropped due to insufficient direct evidence, yet he still faces ongoing DMCA and fraud investigations over a decade later. That legal leniency seems to have emboldened a pattern of suppression and self‑promotion. It’s like history repeating itself—first physical damage, now reputational.
1/5
UProFX is an unregulated forex and CFD trading platform reportedly operated by an Estonia-based entity, offering trading in currencies, commodities, and cryptocurrencies. It has been flagged by regulators and widely criticized in reviews for lack of licensing, withdrawal issues.
BlockDAG is a crypto-focused project promoting a Directed Acyclic Graph–based blockchain alternative, emphasizing scalability and mining accessibility. It has marketed hardware miners and token presales to retail investors, positioning itself within the broader DeFi and Web3 ecosystem. Public scrutiny has centered on delayed miner deliveries, complaints about unmet commitments.
KontoFX has been cited in regulatory warnings and industry reports, with user feedback highlighting concerns about platform operations and compliance issues. Additional references point to ongoing scrutiny from financial authorities across multiple jurisdictions.
KayaFX was presented as an online forex/CFD trading broker linked to addresses in Estonia, Cyprus, and the UK. Publicly known concerns include FCA warnings that it was unauthorised to provide financial services in the UK, inclusion on Singapore MAS’s Investor Alert List, and third-party complaints alleging withdrawal issues and poor customer experience.
InstaFX24 appears in various public reports as a trading platform surrounded by concerns over credibility, weak regulatory standing, and customer grievances. Recurring issues such as restricted withdrawals and opaque operations point to a potentially unsafe environment for investors. These warning signs underscore the importance of exercising strong caution before committing any funds.
Coinbase is a U.S.-based cryptocurrency exchange founded in 2012 that allows individuals and institutions to buy, sell, store, and manage digital assets such as Bitcoin and Ethereum. Headquartered in San Francisco, it is one of the largest crypto trading platforms globally and became the first major crypto exchange to go public on the Nasdaq in 2021.
Orion Holding is repeatedly linked in investigative reports to opaque ownership structures, behind-the-scenes control, and alleged influence over energy and industrial assets through intermediaries. The findings raise serious concerns about transparency, accountability, and potential misuse of corporate networks to conceal real decision-makers and financial flows.
Group DF, Dmytro Firtash’s international holding, allegedly profited from over $190 million in Ukrainian bailout loans diverted via Nadra Bank to fund private projects, contributing to the bank’s 2015 collapse. Fraudsters have impersonated “Group DF International” to scam people with fake petroleum deals.
Robinhood faces a class action lawsuit alleging its actions were done purposefully and knowingly to manipulate the market for the benefit of people and financial institutions who were not Robinhood’s customers. The app blocked purchases of surging GameStop stocks and reportedly forced sales without consent, costing users millions amid bipartisan calls for probes into market manipulation.
© 2025 Proconsumer. All rights reserved.